C
Novo Nordisk A/S NVO
$54.24 -$0.065-0.12% NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
52-Week Range
P/E (TTM)
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -1.57% 1.52% 0.28% 39.06% -21.80%
Total Depreciation and Amortization 18.26% 4,564.69% -96.35% 7.79% -6.42%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items -29.55% 152.68% -157.76% 41.21% 604.98%
Change in Net Operating Assets 131.21% -1,552.92% 91.55% -216.69% 201.66%
Cash from Operations 78.85% 97.32% -72.79% -11.33% 249.63%
Capital Expenditure -17.79% 17.72% -28.85% -18.21% -22.44%
Sale of Property, Plant, and Equipment -- -- -196.95% -- --
Cash Acquisitions -- -- -- 100.00% --
Divestitures -- -- -- -- --
Other Investing Activities -93.40% 4.40% 170.44% 6.47% -176.48%
Cash from Investing -130.24% 92.78% -323.20% -2.98% -619.30%
Total Debt Issued 65.31% -38.87% 37,512.61% -99.66% --
Total Debt Repaid -439.04% -2,678.75% 18.61% 89.47% -1,494.01%
Issuance of Common Stock -- -- -- -- --
Repurchase of Common Stock 100.00% 81.47% -211.48% 67.71% -162.66%
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- 100.00% -- 100.00%
Other Financing Activities -200.00% -- -- -- -200.00%
Cash from Financing -1,014.54% -85.39% 294.14% -212.64% 162.66%
Foreign Exchange rate Adjustments -915.65% -111.84% 299.82% -946.18% -5.41%
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -194.96% 155.56% -1,055.82% -90.78% 671.11%